Gender differences in cardiovascular disease risk factors, treatments and complications in patients with type 2 diabetes: The RIACE Italian multicentre study

Journal of Internal Medicine

Volumn 274, Issue 2, 2013, Pages 176-191

  Penno, G ^a   Solini, A ^a   Bonora, E ^b   Fondelli, C ^c   Orsi, E ^d   Zerbini, G ^e   Trevisan, R ^f   Vedovato, M ^g   Gruden, G ^h   Laviola, L ⁱ   Nicolucci, A ^j   Pugliese, G ^k  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c UNIVERSITY OF SIENA   (Italy)

^d FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^e SAN RAFFAELE HOSPITAL   (Italy)

^f Hospital of Bergamo   (Italy)

^g UNIVERSITY OF PADOVA   (Italy)

^h UNIVERSITY OF TURIN   (Italy)

ⁱ UNIVERSITY OF BARI   (Italy)

^j Consorzio Mario Negri Sud ^*  (Italy)

^k SAPIENZA UNIVERSITY OF ROME   (Italy)

more..

Author keywords

Cardiovascular disease risk factors; Complications; Gender; Treatment disparities; Type 2 diabetes

Indexed keywords

ACARBOSE; ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA SECRETASE INHIBITOR; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EZETIMIBE; FIBRIC ACID DERIVATIVE; GLITAZONE DERIVATIVE; GLUCOSE; HEMOGLOBIN A1C; HEPARIN; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOOP DIURETIC AGENT; LOW DENSITY LIPOPROTEIN; LOW MOLECULAR WEIGHT HEPARIN; METFORMIN; NICOTINIC ACID; OMEGA 3 FATTY ACID; SULFONYLUREA; TETRAHYDROLIPSTATIN; THIAZIDE DIURETIC AGENT; TICLOPIDINE; TRIACYLGLYCEROL; UNINDEXED DRUG; WARFARIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC PATIENT; DISEASE DURATION; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPOTHESIS; ITALY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

CARDIOVASCULAR DISEASE RISK FACTORS; COMPLICATIONS; GENDER; TREATMENT DISPARITIES; TYPE 2 DIABETES;

AGED; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERTENSION; ITALY; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84880328314     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/joim.12073     Document Type: Article

References (47)

1. Yang W, Lu J, Weng J et al. Prevalence of diabetes among men and women in China. N Engl J Med 2010; 362: 1090-101.
2. Hex N, Bartlett C, Wright D, Taylor M, Varley D. Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs. Diabet Med 2012; 29: 855-62.
3. Boussageon R, Bejan-Angoulvant T, Saadatian-Elahi M et al. Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials. BMJ 2011; 343: d4169.
4. Bangalore S, Kumar S, Lobach I, Messerli FH. Blood pressure targets in subjects with type 2 diabetes mellitus/impaired fasting glucose: observations from traditional and bayesian random-effects meta-analyses of randomized trials. Circulation 2011; 123: 2799-810.
5. Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008; 358: 580-91.
6. Ismail-Beigi F. Clinical practice. Glycemic management of type 2 diabetes mellitus. N Engl J Med 2012; 366: 1319-27.
7. Gregg EW, Cheng YJ, Cadwell BL et al. Secular trends in cardiovascular disease risk factors according to body mass index in US adults. JAMA 2005; 293: 1868-74.
8. Hoerger TJ, Zhang P, Segel JE, Gregg EW, Narayan KM, Hicks KA. Improvements in risk factor control among persons with diabetes in the United States: evidence and implications for remaining life expectancy. Diabetes Res Clin Pract 2009; 86: 225-32.
9. Pyörälä K, Lehto S, De Bacquer D et al. Risk factor management in diabetic and non-diabetic patients with coronary heart disease. Findings from the EUROASPIRE I AND II surveys. Diabetologia 2004; 47: 1257-65.
10. Preis SR, Pencina MJ, Hwang SJ et al. Trends in cardiovascular disease risk factors in individuals with and without diabetes mellitus in the Framingham Heart Study. Circulation 2009; 120: 212-20.
11. Davis TM. Ethnic diversity in type 2 diabetes. Diabet Med 2008; 25(Suppl 2): 52-6.
12. Gregg EW, Gu Q, Cheng YJ, Narayan KM, Cowie CC. Mortality trends in men and women with diabetes, 1971 to 2000. Ann Intern Med 2007; 147: 149-55.
13. Preis SR, Hwang SJ, Coady S et al. Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005. Circulation 2009; 119: 1728-35.
14. Gregg EW, Cheng YJ, Saydah S et al. Trends in death rates among U.S. adults with and without diabetes between 1997 and 2006: findings from the National Health Interview Survey. Diabetes Care 2012; 35: 1252-7.
15. Maric C. Risk factors for cardiovascular disease in women with diabetes. Gend Med 2010; 7: 551-6.
16. Emerging Risk Factors Collaboration, Sarwar N, Gao P et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 2010; 375: 2215-22.
17. Huxley R, Barzi F, Woodward M. Excess risk of fatal heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ 2006; 332: 73-8.
18. Solini A, Penno G, Bonora E et al. Diverging association of reduced glomerular filtration rate and albuminuria with coronary and noncoronary events in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study. Diabetes Care 2012; 35: 143-9.
19. Penno G, Solini A, Zoppini G et al. Rate and determinants of association between advanced retinopathy and chronic kidney disease in patients with type 2 diabetes. The Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicentre Study. Diabetes Care 2012; 35: 2317-23.
20. Penno G, Solini A, Bonora E et al. Clinical significance of nonalbuminuric renal impairment in type 2 diabetes. J Hypertens 2011; 29: 1802-9.
21. Pugliese G, Solini A, Fondelli C et al. Reproducibility of albuminuria in type 2 diabetic subjects. Findings from the Renal Insufficiency And Cardiovascular Events (RIACE) Study. Nephrol Dial Transplant 2011; 26: 3950-4.
22. Li C, Ford ES, Tsai J, Zhao G, Balluz LS, Gidding SS. Serum non-high-density lipoprotein cholesterol concentration and risk of death from cardiovascular diseases among U.S. adults with diagnosed diabetes: the Third National Health and Nutrition Examination Survey linked mortality study. Cardiovasc Diabetol 2011; 10: 46.
23. Franzini L, Ardigò D, Cavalot F et al. Women show worse control of type 2 diabetes and cardiovascular disease risk factors than men: Results from the MIND.IT Study Group of the Italian Society of Diabetology. Nutr Metab Cardiovasc Dis 2013; 23: 235-41.
24. Avogaro A, Giorda C, Maggini M et al. Incidence of coronary heart disease in type 2 diabetic men and women: impact of microvascular complications, treatment, and geographic location. Diabetes Care 2007; 30: 1241-7.
25. Ford ES. Trends in the risk for coronary heart disease among adults with diagnosed diabetes in the U.S.: findings from the National Health and Nutrition Examination Survey, 1999-2008. Diabetes Care 2011; 34: 1337-43.
26. Ferrara A, Mangione CM, Kim C et al. Sex disparities in control and treatment of modifiable cardiovascular disease risk factors among patients with diabetes: Translating Research Into Action for Diabetes (TRIAD) Study. Diabetes Care 2008; 31: 69-74.
27. Guthrie B, Emslie-Smith A, Morris AD. Which people with Type 2 diabetes achieve good control of intermediate outcomes? Population database study in a UK region. Diabet Med 2009; 26: 1269-76.
28. Gouni-Berthold I, Berthold HK, Mantzoros CS, Böhm M, Krone W. Sex disparities in the treatment and control of cardiovascular risk factors in type 2 diabetes. Diabetes Care 2008; 31: 1389-91.
29. Wexler DJ, Grant RW, Meigs JB, Nathan DM, Cagliero E. Sex disparities in treatment of cardiac risk factors in patients with type 2 diabetes. Diabetes Care 2005; 28: 514-20.
30. Cavalot F, Petrelli A, Traversa M et al. Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga Diabetes Study. J Clin Endocrinol Metab 2006; 91: 813-9.
31. McFarlane SI, Castro J, Kaur J et al. Control of blood pressure and other cardiovascular risk factors at different practice settings: outcomes of care provided to diabetic women compared to men. J Clin Hypertens (Greenwich) 2005; 7: 73-80.
32. Kautzky-Willer A, Kamyar MR, Gerhat D et al. Sex-specific differences in metabolic control, cardiovascular risk, and interventions in patients with type 2 diabetes mellitus. Gend Med 2010; 7: 571-83.
33. Larkin ME, Backlund JY, Cleary P et al. Disparity in management of diabetes and coronary heart disease risk factors by sex in DCCT/EDIC. Diabet Med 2010; 27: 451-8.
34. Palmieri L, Donfrancesco C. Heart. Prevalence trend of cardiovascular diseases in the Italian adult population. Epidemiol Prev 2011; 35: 94-5.
35. Lloyd-Jones D, Adams RJ, Brown TM et al. Executive summary: heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 2010; 121: 948-54.
36. Kautzky-Willer A, Handisurya A. Metabolic disease and associated complications: sex and gender matter. Eur J Clin Invest 2009; 39: 631-48.
37. Regitz-Zagrosek V, Lehmkuhl E, Mahmoodzadeh S. Gender aspects of the role of the metabolic syndrome as a risk factor for cardiovascular disease. Gend Med 2007; 4(Suppl B): S162-77.
38. Bray GA. Medical consequences of obesity. J Clin Endocrinol Metab 2004; 89: 2583-9.
39. Stamataki KE, Spina J, Rangou DB, Chlouverakis CS, Piaditis GP. Ovarian function in women with non-insulin dependent diabetes mellitus. Clin Endocrinol (Oxf) 1996; 45: 615-21.
40. Ding EL, Song Y, Malik VS, Liu S. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2006; 295: 1288-99.
41. Samaras K, Hayward CS, Sullivan D, Kelly RP, Campbell LV. Effects of postmenopausal hormone replacement therapy on central abdominal fat, glycemic control, lipid metabolism, and vascular factors in type 2 diabetes: a prospective study. Diabetes Care 1999; 22: 1401-7.
42. Wang GJ, Volkow ND, Telang F et al. Evidence of gender differences in the ability to inhibit brain activation elicited by food stimulation. Proc Natl Acad Sci USA 2009; 106: 1249-54.
43. Khan NA, Yun L, Humphries K, Kapral M. Antihypertensive drug use and adherence after stroke: are there sex differences? Stroke 2010; 41: 1445-9.
44. Wong MC, Lau RK, Jiang JY, Griffiths SM. Discontinuation of angiotensin-converting enzyme inhibitors: a cohort study. J Clin Pharm Ther 2012; 37: 335-41.
45. ISTAT, Annuario statistico italiano 2011, http://www3.istat.it/dati/catalogo/20111216_00/contenuti.html.
46. Osservatorio ARNO Diabete, Rapporto 2011, http://www.cureprimarie-ulss21.it/page.asp?id=2499&title=pubblicato-il-rapporto-dellosservatorio-arno-sul-diabete.
47. Annali AMD 2009, http://www.infodiabetes.it/files/2009_annali_AMD_ita.pdf.